Barclays upgraded CVS Health Corp (NYSE:CVS) shares to Overweight from Equal Weight, citing a promising outlook for the company's margin recovery. The firm also raised its price target for CVS shares ...

A federal antitrust watchdog is already conducting an investigation into and has filed a lawsuit against huge pharmacy ...

Russell's Pharmacy & Shoppe's last day on Angier Avenue is October 19. Its closure comes as independent pharmacies around the ...

TD Cowen upgraded CVS Health (NYSE: CVS) to Buy from Hold, raising its price target to $85 from $59. This represents a ...

The companies argue the commissioners have "a lengthy track record of making public statements that indicate serious bias" ...

Whatever the outcome of the countering lawsuits, it will be a challenging period for PBMs, given the FTC's actions on alleged ...

CVS Health (CVS) stock receives an upgrade from TD Cowen to Buy with a price target of $85, based on favorable Medicare ...

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Charles Rhyee ...

Medicare Advantage plans are government Medicare benefits provided through for-profit insurers, so plan terms can — and do — change ...

Today’s pharmacy innovations provide employees with expanded choices to meet their health care needs. As a result, they ...

The bill, which was introduced July 23 in the House, is aimed at implementing a pharmacy reimbursement model to use national ...

Looking for undervalued stocks? Here are the top undervalued stocks in November 2024. Check out the list here.